Approved Symbol |
Approved Name |
Location |
No. of Studies (Positive/Negative/Trend) |
Evidence[PMID] |
NRXN3 |
neurexin 3 |
14q31 |
2(2/0/0)
|
TAS[1621094]
|
NRG3 |
neuregulin 3 |
10q23.1 |
2(0/2/0)
|
NAS[9275162]
|
SLC1A4 |
solute carrier family 1 (glutamate/neutral amino acid transporter), member 4 |
2p15-p13 |
1(0/1/0)
|
IC[8910405]
|
CMKLR1 |
chemokine-like receptor 1 |
12q23.3 |
1(0/1/0)
|
TAS[9425281]
|
KCNMB2 |
potassium channel subfamily M regulatory beta subunit 2 |
3q26.32 |
1(1/0/0)
|
IDA[10692449]
|
MTNR1A |
melatonin receptor 1A |
4q35 |
1(0/1/0)
|
IDA[10531408]
|
HLA-A |
major histocompatibility complex, class I, A |
6p21.3 |
1(0/1/0)
|
NAS[6609814]
|
TSHR |
thyroid stimulating hormone receptor |
14q24-q31 |
1(1/0/0)
|
TAS[8552586]
|
CTLA4 |
cytotoxic T-lymphocyte-associated protein 4 |
2q33 |
2(1/1/0)
|
TAS[3220103]
|
GABRB1 |
gamma-aminobutyric acid (GABA) A receptor, beta 1 |
4p12 |
3(2/0/1)
|
ISS
|
CHRM1 |
cholinergic receptor, muscarinic 1 |
11q12-q13 |
1(0/1/0)
|
IEA
|
NPFFR2 |
neuropeptide FF receptor 2 |
4q21 |
1(0/1/0)
|
TAS[10079187]
|
PTPRZ1 |
protein tyrosine phosphatase, receptor-type, Z polypeptide 1 |
7q31.3 |
1(1/0/0)
|
TAS[8387522]
|
ADRB2 |
adrenoceptor beta 2, surface |
5q31-q32 |
1(1/0/0)
|
IDA[12297500]
|
PTGFR |
prostaglandin F receptor (FP) |
1p31.1 |
1(1/0/0)
|
TAS[8300593]
|
AGTR1 |
angiotensin II receptor, type 1 |
3q24 |
1(1/0/0)
|
IC[1378723]
|
GRM7 |
glutamate receptor, metabotropic 7 |
3p26-p25 |
3(2/1/0)
|
NAS[9473604]
|
SLC4A11 |
solute carrier family 4, sodium borate transporter, member 11 |
20p13 |
1(0/1/0)
|
IBA
|
GABRR1 |
gamma-aminobutyric acid (GABA) A receptor, rho 1 |
6q15 |
1(1/0/0)
|
TAS[10779366]
|
SLC6A2 |
solute carrier family 6 (neurotransmitter transporter), member 2 |
16q12.2 |
2(0/2/0)
|
IEA
|
SLC14A1 |
solute carrier family 14 (urea transporter), member 1 (Kidd blood group) |
18q11-q12 |
1(0/1/0)
|
IDA[19865084]
|
CCKBR |
cholecystokinin B receptor |
11p15.4 |
1(1/0/0)
|
IC[10913157]
|
MC5R |
melanocortin 5 receptor |
18p11.2 |
1(0/1/0)
|
TAS[7739752]
|
ROR1 |
receptor tyrosine kinase-like orphan receptor 1 |
1p31.3 |
1(0/0/1)
|
TAS[1334494]
|
GRM4 |
glutamate receptor, metabotropic 4 |
6p21.3 |
2(2/0/0)
|
IDA[15102938]
|
TRPM2 |
transient receptor potential cation channel, subfamily M, member 2 |
21q22.3 |
5(3/2/0)
|
TAS[9806837]
|
MUC4 |
mucin 4, cell surface associated |
3q29 |
2(0/2/0)
|
TAS[10024507]
|
ADRA2A |
adrenoceptor alpha 2A |
10q25.2 |
1(0/1/0)
|
IDA[10948191]
|
ROR2 |
receptor tyrosine kinase-like orphan receptor 2 |
9q22 |
1(0/1/0)
|
TAS[1334494]
|
NRXN1 |
neurexin 1 |
2p16.3 |
1(1/0/0)
|
TAS[1621094]
|
HTR2C |
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled |
Xq23 |
7(4/3/0)
|
IMP[18703043]
|
NOTCH4 |
notch 4 |
6p21.3 |
2(0/2/0)
|
TAS[11823422]
|
SSTR5 |
somatostatin receptor 5 |
16p13.3 |
2(1/1/0)
|
TAS[7908405]
|
HTR1A |
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled |
5q11.2-q13 |
3(2/1/0)
|
IDA[22957663]
|
CHRM3 |
cholinergic receptor, muscarinic 3 |
1q43 |
1(0/1/0)
|
ISS
|
ADORA2B |
adenosine A2b receptor |
17p12 |
1(1/0/0)
|
TAS[7558011]
|
TFRC |
transferrin receptor |
3q29 |
1(0/1/0)
|
TAS[6090955]
|
TAAR6 |
trace amine associated receptor 6 |
6q23.1 |
5(4/1/0)
|
IBA
|
ADCY9 |
adenylate cyclase 9 |
16p13.3 |
2(1/1/0)
|
TAS[9628827]
|
HCRTR2 |
hypocretin (orexin) receptor 2 |
6p12.1 |
1(1/0/0)
|
TAS[9491897]
|
PLXNA2 |
plexin A2 |
1q32.2 |
1(1/0/0)
|
ISS
|
GRM3 |
glutamate receptor, metabotropic 3 |
7q21.1-q21.2 |
7(3/4/0)
|
IBA
|
HTR7 |
5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled |
10q21-q24 |
2(0/2/0)
|
TAS[8226867]
|
IL17RA |
interleukin 17 receptor A |
22q11.1 |
1(0/1/0)
|
NAS[9367539]
|
PTPRO |
protein tyrosine phosphatase, receptor type, O |
12p13-p12 |
1(0/1/0)
|
NAS[7665166]
|
GRIK4 |
glutamate receptor, ionotropic, kainate 4 |
11q23.3 |
2(1/1/0)
|
TAS[8263508]
|
GABRA4 |
gamma-aminobutyric acid (GABA) A receptor, alpha 4 |
4p12 |
2(2/0/0)
|
TAS[8719416]
|
HCAR3 |
hydroxycarboxylic acid receptor 3 |
12q24.31 |
1(0/1/0)
|
TAS[7505609]
|
HTR1F |
5-hydroxytryptamine (serotonin) receptor 1F, G protein-coupled |
3p12 |
1(1/0/0)
|
IMP[21422162]
|
HTR4 |
5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled |
5q31-q33 |
2(1/1/0)
|
IEA
|
EDA2R |
ectodysplasin A2 receptor |
Xq11.1 |
1(0/0/1)
|
IEA
|
EPHA5 |
EPH receptor A5 |
4q13.1 |
1(1/0/0)
|
IEA
|
ABCG1 |
ATP-binding cassette, sub-family G (WHITE), member 1 |
21q22.3 |
1(0/1/0)
|
IC[11500512]
|
AVPR1B |
arginine vasopressin receptor 1B |
1q32 |
4(3/1/0)
|
TAS[7805841]
|
ABCC11 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 11 |
16q12 |
1(0/0/1)
|
IDA[16359813]
|
GABRB3 |
gamma-aminobutyric acid (GABA) A receptor, beta 3 |
15q12 |
3(1/2/0)
|
IMP[22303015]
|
SLC17A3 |
solute carrier family 17 (organic anion transporter), member 3 |
6p22.2 |
1(1/0/0)
|
IDA[20810651]
|
AQP8 |
aquaporin 8 |
16p12 |
1(0/0/1)
|
TAS[9806845]
|
GRIK2 |
glutamate receptor, ionotropic, kainate 2 |
6q16.3 |
3(1/1/1)
|
TAS[7536611]
|
DRD5 |
dopamine receptor D5 |
4p16.1 |
2(0/2/0)
|
NAS[1826762]; TAS[9457173]
|
TRHR |
thyrotropin-releasing hormone receptor |
8q23.1 |
1(0/1/0)
|
TAS[8395824]
|
PLA2R1 |
phospholipase A2 receptor 1, 180kDa |
2q23-q24 |
1(1/0/0)
|
NAS[7721806]
|
OR5AS1 |
olfactory receptor, family 5, subfamily AS, member 1 |
11q11 |
1(0/0/1)
|
IBA
|
DRD2 |
dopamine receptor D2 |
11q22-q23 |
28(8/20/0)
|
IC[2531656]; IDA[8413587]
|
TAAR1 |
trace amine associated receptor 1 |
6q23.1 |
1(0/1/0)
|
IBA
|
P2RX4 |
purinergic receptor P2X, ligand gated ion channel, 4 |
12q24.32 |
1(0/1/0)
|
IC[11606481]; IMP[10515189]
|
ADRA1B |
adrenoceptor alpha 1B |
5q33.3 |
1(1/0/0)
|
TAS[1328250]
|
FAM26F |
family with sequence similarity 26, member F |
6q22.1 |
1(1/0/0)
|
IBA
|
SLC15A1 |
solute carrier family 15 (oligopeptide transporter), member 1 |
13q32.3 |
1(0/1/0)
|
TAS[7896779]
|
CHRNB4 |
cholinergic receptor, nicotinic, beta 4 (neuronal) |
15q24 |
2(1/1/0)
|
IC[11742001]
|
ATP2A2 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
12q24.11 |
2(0/2/0)
|
TAS[2844796]
|
MARCO |
macrophage receptor with collagenous structure |
2q14.2 |
1(0/1/0)
|
TAS[9468508]
|
HLA-B |
major histocompatibility complex, class I, B |
6p21.3 |
2(0/1/1)
|
NAS[518865]
|
VAMP2 |
vesicle-associated membrane protein 2 (synaptobrevin 2) |
17p13.1 |
1(1/0/0)
|
TAS[1976629]
|
ABCA13 |
ATP-binding cassette, sub-family A (ABC1), member 13 |
7p12.3 |
2(2/0/0)
|
IBA
|
MCHR1 |
melanin-concentrating hormone receptor 1 |
22q13.3 |
2(1/1/0)
|
TAS[10421367]
|
PTPRN2 |
protein tyrosine phosphatase, receptor type, N polypeptide 2 |
7q36 |
1(0/0/1)
|
TAS[8798755]
|
CHRNB1 |
cholinergic receptor, nicotinic, beta 1 (muscle) |
17p13.1 |
1(1/0/0)
|
NAS[8872460]
|
DSCAM |
Down syndrome cell adhesion molecule |
21q22.2-q22.3 |
3(1/2/0)
|
TAS[9426258]
|
GPR50 |
G protein-coupled receptor 50 |
Xq28 |
3(2/1/0)
|
TAS[8647286]
|
GRIN1 |
glutamate receptor, ionotropic, N-methyl D-aspartate 1 |
9q34.3 |
3(2/1/0)
|
IDA[7685113]
|
DRD3 |
dopamine receptor D3 |
3q13.3 |
19(4/15/0)
|
IC[8301582]; IDA[8413587]
|
GJA8 |
gap junction protein, alpha 8, 50kDa |
1q21.1 |
1(1/0/0)
|
TAS[7796604]
|
NTRK2 |
neurotrophic tyrosine kinase, receptor, type 2 |
9q22.1 |
3(1/1/1)
|
IDA[15494731]
|
ADRA1A |
adrenoceptor alpha 1A |
8p21.2 |
2(0/2/0)
|
TAS[8396931]
|
CD36 |
CD36 molecule (thrombospondin receptor) |
7q11.2 |
3(2/1/0)
|
TAS[9568716]
|
GABRA1 |
gamma-aminobutyric acid (GABA) A receptor, alpha 1 |
5q34 |
2(1/1/0)
|
ISS
|
NRG1 |
neuregulin 1 |
8p12 |
15(10/5/0)
|
IEA
|
BDKRB1 |
bradykinin receptor B1 |
14q32.1-q32.2 |
1(1/0/0)
|
TAS[8063797]
|
TNF |
tumor necrosis factor |
6p21.3 |
4(2/2/0)
|
IDA[18355445]
|
GRIN2A |
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
16p13.2 |
1(1/0/0)
|
TAS[8768735]
|
GRIK3 |
glutamate receptor, ionotropic, kainate 3 |
1p34.3 |
1(1/0/0)
|
IDA[7719709]
|
DRD4 |
dopamine receptor D4 |
11p15.5 |
13(1/12/0)
|
IDA[15755724]
|
SLC1A1 |
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 |
9p24 |
1(1/0/0)
|
TAS[7521911]
|
SSTR1 |
somatostatin receptor 1 |
14q13 |
1(1/0/0)
|
TAS[1346068]
|
BDKRB2 |
bradykinin receptor B2 |
14q32.1-q32.2 |
1(1/0/0)
|
TAS[7916737]
|
STEAP3 |
STEAP family member 3, metalloreductase |
2q14.2 |
1(0/0/1)
|
IBA
|
GABRA5 |
gamma-aminobutyric acid (GABA) A receptor, alpha 5 |
15q12 |
6(6/0/0)
|
TAS[1321750]
|
NUMB |
numb homolog (Drosophila) |
14q24.3 |
1(0/0/1)
|
TAS[7596406]
|
SLC2A9 |
solute carrier family 2 (facilitated glucose transporter), member 9 |
4p16.1 |
1(0/0/1)
|
IEA
|
TACR1 |
tachykinin receptor 1 |
2p13.1-p12 |
3(3/0/0)
|
TAS[1657150]
|
CHRM5 |
cholinergic receptor, muscarinic 5 |
15q26 |
1(0/1/0)
|
IEA
|
NTSR2 |
neurotensin receptor 2 |
2p25.1 |
1(1/0/0)
|
TAS[9851594]
|
SIGLEC6 |
sialic acid binding Ig-like lectin 6 |
19q13.3 |
1(1/0/0)
|
TAS[9465907]
|
GJA5 |
gap junction protein, alpha 5, 40kDa |
1q21.2 |
1(1/0/0)
|
IDA[22247482]
|
TENM2 |
teneurin transmembrane protein 2 |
5q35 |
1(0/0/1)
|
IEA
|
GJA1 |
gap junction protein, alpha 1, 43kDa |
6q22.31 |
1(1/0/0)
|
TAS[15709751]
|
SLC6A3 |
solute carrier family 6 (neurotransmitter transporter), member 3 |
5p15.3 |
11(5/6/0)
|
IEA
|
VIPR2 |
vasoactive intestinal peptide receptor 2 |
7q36.3 |
1(1/0/0)
|
TAS[7811244]
|
HCRTR1 |
hypocretin (orexin) receptor 1 |
1p33 |
1(1/0/0)
|
TAS[9491897]
|
HTR2A |
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled |
13q14-q21 |
22(7/15/0)
|
IEA
|
CSF2RB |
colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) |
22q12.3 |
2(1/1/0)
|
NAS[1702217]
|
CRHR1 |
corticotropin releasing hormone receptor 1 |
17q21.31 |
4(2/2/0)
|
TAS[10598591]
|
SLC6A4 |
solute carrier family 6 (neurotransmitter transporter), member 4 |
17q11.2 |
44(18/26/0)
|
IC[19270731]
|
HTR3B |
5-hydroxytryptamine (serotonin) receptor 3B, ionotropic |
11q23.1 |
2(1/1/0)
|
IEA
|
MMP16 |
matrix metallopeptidase 16 (membrane-inserted) |
8q21 |
1(0/1/0)
|
TAS[7559440]
|
CNR2 |
cannabinoid receptor 2 (macrophage) |
1p |
1(1/0/0)
|
TAS[8679694]
|
PTPRD |
protein tyrosine phosphatase, receptor type, D |
9p24.1-p23 |
1(0/0/1)
|
TAS[7896816]
|
HTR3A |
5-hydroxytryptamine (serotonin) receptor 3A, ionotropic |
11q23.1-q23.2 |
2(1/1/0)
|
TAS[7565620]
|
GABRB2 |
gamma-aminobutyric acid (GABA) A receptor, beta 2 |
5q34 |
1(1/0/0)
|
ISS
|
GABBR2 |
gamma-aminobutyric acid (GABA) B receptor, 2 |
9q22.1-q22.3 |
2(0/2/0)
|
IDA[9872316]
|
GRIN2B |
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
12p13.1 |
8(4/4/0)
|
TAS[8768735]
|
GABRA3 |
gamma-aminobutyric acid (GABA) A receptor, alpha 3 |
Xq28 |
3(1/2/0)
|
TAS[8391122]
|
GABRA6 |
gamma-aminobutyric acid (GABA) A receptor, alpha 6 |
5q34 |
1(0/1/0)
|
TAS[8632757]
|
HTR5A |
5-hydroxytryptamine (serotonin) receptor 5A, G protein-coupled |
7q36.1 |
2(1/1/0)
|
IEA
|
SLC18A2 |
solute carrier family 18 (vesicular monoamine transporter), member 2 |
10q25 |
1(1/0/0)
|
TAS[8095030]
|
HTR1E |
5-hydroxytryptamine (serotonin) receptor 1E, G protein-coupled |
6q14-q15 |
1(0/1/0)
|
IMP[21422162]
|
CHRM2 |
cholinergic receptor, muscarinic 2 |
7q35-q36 |
1(0/1/0)
|
IDA[24256733]
|
HTR6 |
5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled |
1p36-p35 |
3(1/2/0)
|
TAS[8522988]
|
GRM2 |
glutamate receptor, metabotropic 2 |
3p21.2 |
1(0/1/0)
|
IBA
|
CACNB2 |
calcium channel, voltage-dependent, beta 2 subunit |
10p12 |
3(2/1/0)
|
NAS[9594024]
|
IL2RB |
interleukin 2 receptor, beta |
22q13 |
2(1/1/0)
|
TAS[8514792]
|
GPC5 |
glypican 5 |
13q32 |
1(0/0/1)
|
TAS[7657705]
|
P2RX7 |
purinergic receptor P2X, ligand gated ion channel, 7 |
12q24 |
9(2/7/0)
|
IC[9038151]
|
KCNK10 |
potassium channel, two pore domain subfamily K, member 10 |
14q31 |
1(1/0/0)
|
IBA
|
TAAR8 |
trace amine associated receptor 8 |
6q23.2 |
1(0/1/0)
|
IBA
|
TENM4 |
teneurin transmembrane protein 4 |
11q13 |
6(4/2/0)
|
IEA
|
KCND2 |
potassium channel, voltage gated Shal related subfamily D, member 2 |
7q31 |
1(1/0/0)
|
IDA[24811166]
|
SLC20A1 |
solute carrier family 20 (phosphate transporter), member 1 |
2q13 |
1(0/1/0)
|
TAS[8041748]
|
CHRM4 |
cholinergic receptor, muscarinic 4 |
11p12-p11.2 |
1(0/1/0)
|
IEA
|
CHRNA9 |
cholinergic receptor, nicotinic, alpha 9 (neuronal) |
4p14 |
2(0/2/0)
|
IDA[25282151]
|
NTRK3 |
neurotrophic tyrosine kinase, receptor, type 3 |
15q24-q25 |
2(2/0/0)
|
IEA
|
GPR87 |
G protein-coupled receptor 87 |
3q24 |
1(1/0/0)
|
IBA
|
TLR4 |
toll-like receptor 4 |
9q33.1 |
1(1/0/0)
|
IDA[15027902]
|
P2RY13 |
purinergic receptor P2Y, G-protein coupled, 13 |
3q24 |
1(1/0/0)
|
IBA
|
OXTR |
oxytocin receptor |
3p25 |
1(0/1/0)
|
TAS[10858434]
|
DRD1 |
dopamine receptor D1 |
5q34-q35 |
11(6/5/0)
|
IBA; IC[2144334]
|
CNR1 |
cannabinoid receptor 1 (brain) |
6q14-q15 |
5(0/5/0)
|
TAS[1718258]
|
ADRA2C |
adrenoceptor alpha 2C |
4p16.3 |
1(0/1/0)
|
IDA[16605244]
|
CRHR2 |
corticotropin releasing hormone receptor 2 |
7p14.3 |
3(2/1/0)
|
TAS[8536644]
|
HTR1D |
5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled |
1p36.3-p34.3 |
1(0/1/0)
|
IDA[1652050]
|
FGFR2 |
fibroblast growth factor receptor 2 |
10q25.3-q26 |
2(1/1/0)
|
IDA[15629145]
|
SYPL1 |
synaptophysin-like 1 |
7q22.2 |
1(1/0/0)
|
TAS[8034131]
|
GLRA1 |
glycine receptor, alpha 1 |
5q33.1 |
1(1/0/0)
|
IDA[7506679]; IMP[11973623]; NAS[2155780]
|
TM9SF2 |
transmembrane 9 superfamily member 2 |
13q32.2 |
1(0/0/1)
|
TAS[9729438]
|
KCNH7 |
potassium channel, voltage gated eag related subfamily H, member 7 |
2q24.3 |
3(2/0/1)
|
IBA
|
SLC12A6 |
solute carrier family 12 (potassium/chloride transporter), member 6 |
15q13 |
1(1/0/0)
|
IEA
|
ANK2 |
ankyrin 2, neuronal |
4q25-q26 |
1(0/1/0)
|
IEA
|